Genentech’s Alzheimer’s Drug Garners Breakthrough Therapy Designation

October 11th 2021

Genentech is conducting phase 3 trials of gantenerumab, an anti-amyloid antibody.

Merck Seeks EUA for COVID-19 Treatment

October 11th 2021

Molnupiravir reduced the risk of hospitalization or death by about 50%.

Drug Shortages Update — October 10, 2021

October 10th 2021

Pfizer Seeks EUA for COVID-19 Vaccine in Children

October 8th 2021

The announcement was made by Pfizer and BioNTech on Twitter

Janssen Submits Application for Stelara for Psoriatic Arthritis in Children

October 8th 2021

An FDA decision is expected in late 2022.